These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11282244)

  • 1. Activity of mammalian secreted phospholipase A(2) from inflammatory peritoneal fluid towards PEG-liposomes. Early indications.
    Vermehren C; Jørgensen K; Schiffelers R; Frokjaer S
    Int J Pharm; 2001 Feb; 214(1-2):93-8. PubMed ID: 11282244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of a lipid-membrane destabilizing enzyme with PEG-liposomes.
    Jørgensen K; Kiebler T; Hylander I; Vermehren C
    Int J Pharm; 1999 Jun; 183(1):21-4. PubMed ID: 10361147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery by phospholipase A(2) degradable liposomes.
    Davidsen J; Vermehren C; Frokjaer S; Mouritsen OG; Jørgensen K
    Int J Pharm; 2001 Feb; 214(1-2):67-9. PubMed ID: 11282239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
    Arouri A; Mouritsen OG
    Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in phospholipase A2 activity towards lipopolymer-containing liposomes.
    Vermehren C; Kiebler T; Hylander I; Callisen TH; Jørgensen K
    Biochim Biophys Acta; 1998 Aug; 1373(1):27-36. PubMed ID: 9733909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lipopolymer concentration on liposome degradation and blood clearance.
    Vermehren C; Jørgensen K; Frokjaer S
    Int J Pharm; 1999 Jun; 183(1):13-6. PubMed ID: 10361145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ethylene glycol)-lipid conjugates inhibit phospholipase C-induced lipid hydrolysis, liposome aggregation and fusion through independent mechanisms.
    Basáñez G; Goñi FM; Alonso A
    FEBS Lett; 1997 Jul; 411(2-3):281-6. PubMed ID: 9271221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade liposomal triggering: light-induced Ca2+ release from diplasmenylcholine liposomes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes.
    Wymer NJ; Gerasimov OV; Thompson DH
    Bioconjug Chem; 1998; 9(3):305-8. PubMed ID: 9576803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of phospholipase A2 catalyzed degradation of polymer grafted PEG-liposomes: effects of lipopolymer-concentration and chain-length.
    Jørgensen K; Vermehren C; Mouritsen OG
    Pharm Res; 1999 Sep; 16(9):1491-3. PubMed ID: 10496671
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation.
    Sevanian A; Wratten ML; McLeod LL; Kim E
    Biochim Biophys Acta; 1988 Aug; 961(3):316-27. PubMed ID: 3401498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
    J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening effect of PEG on avidin binding to liposome surface receptors.
    Kaasgaard T; Mouritsen OG; Jørgensen K
    Int J Pharm; 2001 Feb; 214(1-2):63-5. PubMed ID: 11282238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 2000 May; 201(1):37-49. PubMed ID: 10867263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
    Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
    J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
    Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxidation and phospholipase A2 hydrolytic susceptibility of liposomes consisting of mixed species of phosphatidylcholine and phosphatidylethanolamine.
    Salgo MG; Corongiu FP; Sevanian A
    Biochim Biophys Acta; 1992 Jul; 1127(2):131-40. PubMed ID: 1643097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether.
    Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of secretory phospholipase A(2) enzyme by bilirubin: a new role as endogenous anti-inflammatory molecule.
    Jameel NM; Frey BM; Frey FJ; Gowda TV; Vishwanath BS
    Mol Cell Biochem; 2005 Aug; 276(1-2):219-25. PubMed ID: 16132704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.